Observational studyPloS one2023

Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study.

Rafael Venegas-Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.